Trudeau Institute appoints new board of directors | News, Sports, Jobs


Kip Testwuide (Photo provided)

LAC SARANAC – The Trudeau Institute has elected Kip Testwuide, Investment Banker and Managing Member of High Peaks Advisors LLC, as the new Chairman of the Board.

Testwuide, of Lake Placid, holds the post left by Dr. Dorothy Federman, who retired as president in August after serving on Trudeau’s board of directors for 40 years.

Julie North, partner at the law firm Cravath, Swaine & Moore, and Dr. Brian Pollok, co-founder, president and CEO of biotech company Propagenix Inc., have been appointed co-vice-presidents.

Victoria Derbyshire, a public health expert who served as deputy director of the Wadsworth Center in Albany, has also been appointed to the board.

“It is a remarkable honor to follow in Dorothy’s footsteps”, said Testwuide, who has served on Trudeau’s board of directors since 2018. “Dorothy has been a surefire guide and inspiration as Trudeau continues to evolve.

“Under his leadership, we have strengthened our commitment to protect global health by strengthening our own research initiatives and leveraging these capacities to work more closely with outside institutions,” he added. “We are all grateful for his vision and his long service. “

Federman, who has chaired Trudeau since 2019, joined its board in 1981. At the time, she had recently launched her medical career at Saranac Lake and was working alongside Frank Trudeau, founding president of the institute. When he asked her to join the board, Federman recalls, she wasn’t even sure what a board was doing. But her experience as a doctor and as a scientist’s daughter helped her level up quickly.

“I resign at the time of Trudeau’s rise”, said Federman. “Trudeau has his feet firmly planted below. Our newer and younger board members ask questions I never thought would ask and inhabit areas of thought critical to the continuing success of the institute. They are ready to carry the torch and it is time for me to become an ambassador.

Trudeau President and Director Atsuo Kuki announced that Trudeau would rename his Early Career Scholars Program Dorothy J. Federman Postdoctoral Program, and dedicated a terrace in his honor. He praised Federman’s leadership and generosity as she stepped down.

“Under his guidance, the Trudeau Company has taken action against some of the most pressing threats to global health as we preserve, honor and extend the Trudeau legacy,” Kuki said. “Dorothy has been a direct link between Frank Trudeau and the dynamic legacy of our history, right down to the modern challenges of drug-resistant tuberculosis and the novel coronavirus.

“We have hired new teams of scientists and research technicians who bring their specific skills to our unique laboratory”, he added. “We have broadened our dedication to the region’s economic strength and, at the same time, to the medical well-being of our northern community, something clearly brought relief when we partnered with institutions in the region to fight against the COVID-19 pandemic. ”

Federman’s successor, Testwuide, has served as Trudeau’s vice president since 2019. Testwuide had a 30-year career in investment banking in New York City, most recently heading the fixed income division of BNP Paribas in the Americas.

He is a member of Point Positive, an angel investor group growing new businesses in Adirondack Park. He also serves on the boards of the Adirondack Land Trust, the New York State Ski Education Foundation, the University of Wisconsin, the College of Letters and Science and the Beaver Dam Sanctuary. Testwuide lives in Lake Placid.

North, a partner in the litigation department of the New York law firm Cravath, Swaine & Moore, has served on Trudeau’s board of directors since 2013. She has a long-standing relationship with the institute: her father, Robert North, was Trudeau’s third director and remains honorary trustee. North is a board member of Central City Chorus and Everybody Wins! New York; She also sits on the Advocates Council of Human Rights First and the Legal Momentum Council of Legal Advisors. She lives in New York.

Pollok is co-founder, president and CEO of Propagenix Inc., a Maryland-based biotechnology company specializing in epithelial tissue modeling and cell therapy.

During his 40-year career, Pollok served in the medical school at Wake Forest University. He has served as a senior biotech research and development executive for several Fortune 500 companies and was president of the country’s oldest not-for-profit biotech organization. He was the University of Virginia’s first Entrepreneur in Residence, where he launched two biotech startups as CEOs.

He has served on several not-for-profit boards related to biomedical research, including the Muscular Dystrophy Association, the NIH Center for Regenerative Medicine, and the Dean’s Office at UCSD. He is an instructor at the Osher Lifelong Learning Institute at AVU and lives in Albemarle County, Virginia.

Derbyshire spent 28 years at the Wadsworth Center in Albany, where she served as Deputy Director for seven years.

Originally from England, Derbyshire joined Wadsworth in 1992 as an NIH-supported postdoctoral fellow. She holds a doctorate in molecular biophysics and biochemistry from Yale University, as well as a patent on the use of inteins to purify proteins. She lives in Slingerlands.

The latest news today and more in your inbox


Comments are closed.